However, when downstream signaling proteins are mutated, TGF-β suppresses the development of immune cells and allows for the metastasis and growth of prostate, lung, and breast cancer CSCs (Bellomo et al., 2016; Futakuchi et al., 2019). Here, TGFB1 is linked to breast carcinoma.